BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novartis Corporation 

608 5th Avenue

New York  New York  10020  U.S.A.
Phone: 212-307-1122 Fax: 212-246-0185


SEARCH JOBS






Collaborations

Isis Pharmaceuticals, Inc. 

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Incyte Corporation 

Celgene  Discovery and Development of Selective estrogen receptor modulators for the treatment of osteoporosis

Celgene  Commercialization of FocalinTM for ADHD

Rigel Pharmaceuticals, Inc. 

Entelos, Inc. 

Human Genome Sciences, Inc. 

Peptimmune, Inc.  Exclusive option to obtain exclusive worldwide rights to develop and commercialize PI-2301, Peptimmune’s multiple sclerosis drug candidate.

Cubist Pharmaceuticals, Inc. 





 Company News
Novartis Corporation (NVS) Breakthrough Therapy LDK378 Shows a Marked Clinical Response in Patients With ALK+ Non-Small Cell Lung Cancer 6/3/2013 11:47:29 AM
Novartis Corporation (NVS) Release: 8 Scottish Life Science Companies Descend Upon Boston in Search of Investors and Partners 6/15/2012 9:57:10 AM
Novartis Corporation (NVS) Sits in the Penalty Box 4/25/2012 8:07:17 AM
FDA Approves Novartis Corporation (NVS)'s Gleevec for Expanded Use in Patients With Rare Gastrointestinal Cancer 2/1/2012 6:44:03 AM
Endo Pharmaceuticals (ENDP) Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis Corporation (NVS)Facility 1/9/2012 11:51:10 AM
Novartis Corporation (NVS) Pivotal Study of Exjade(R) Shows Significant Reduction of Iron Overload in Patients with Non-transfusion-dependent Thalassemia 12/13/2011 11:39:43 AM
Novartis Corporation (NVS) Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis 11/7/2011 11:40:52 AM
Viamet Pharmaceuticals Appoints Former Novartis Corporation (NVS) Executive Marc Rudoltz, M.D. as Chief Medical Officer 11/3/2011 9:17:37 AM
Novartis Corporation (NVS) Release: IBM Corporation (IBM) Launches University Competition to Combat Growth of Non-Communicable Diseases 10/10/2011 6:01:01 AM
Novartis AG (NVS) Receives Approval in Japan for Two Innovative Therapies, Gilenya(R) in MS and Ilaris(R) in CAPS 9/27/2011 7:43:31 AM
12345678910...